Tamtam Try Tamtam free
DECIEM | THE ABNORMAL BEAUTY COMPANY logo

DECIEM | THE ABNORMAL BEAUTY COMPANY account plan

Creating innovative beauty products

At a glance

DECIEM, parent of The Ordinary, is a Toronto beauty group inside Estée Lauder; The Ordinary is a Scaling Brand ($400m to under $1,000m).

DECIEM, The Abnormal Beauty Company, is the Toronto-based parent company of The Ordinary, and its Toronto lab and production facilities develop and produce The Ordinary products in-house. It is owned by The Estée Lauder Companies, whose reports list The Ordinary among its Scaling Brands (net sales of $400 million to under $1,000 million) and NIOD, Avestan and Loopha among its Developing Brands. Estée Lauder reported fiscal 2026 net sales of $15,049 million (year to June 30, 2026) and approximately 55,000 employees. The Ordinary is sold in the entry price tier and opened its first standalone Malaysian boutiques in 2025.

Business units

Strategic priorities

Scale The Ordinary as a Scaling Brand
Estée Lauder groups The Ordinary with Le Labo, Bobbi Brown Cosmetics and Aveda as Scaling Brands, and its first quarter call credits it with double-digit growth in skin care, in Mainland China prestige share gains and in Hair Care via its Multi-Peptide Serum for Hair Density.
Grow share at the entry of prestige
Management said it is "gaining market share in M·A·C and The Ordinary", and wants to apply the M·A·C and The Ordinary playbook at the entry of prestige to other brands such as Bobbi Brown, Clinique and Estée Lauder.
Expand in Asia Pacific and Southeast Asia
DECIEM's CEO said Malaysia felt like the natural next step after "the continued success of The Ordinary in the Asia Pacific region", with stores designed to offer tailored skincare education and support. In Mainland China The Ordinary led prestige share gains alongside TOM FORD, Le Labo and La Mer.
Keep launches science-led and slow to hype
The brand only launches "when it's ready, effective and makes sense for our community", and chooses education first over entertainment content.
Build a 3-year innovation pipeline
DECIEM's CEO said a 3-year plan for new product innovations is in development, kept flexible around ingredient efficacy, formulation stability and scientific advances.

Latest results

In Estée Lauder's fiscal 2027 first quarter (three months to September 30, 2026), Skin Care net sales were $1,651 million, up 5%, and La Mer and The Ordinary together added approximately $97 million. The Ordinary grew from targeted expanded consumer reach and key campaigns, and in Hair Care from its Multi-Peptide Serum for Hair Density. On the call, skin care organic sales rose 4%, "primarily driven by double-digit growth from La Mer and The Ordinary". The Ordinary was also among the brands leading Estée Lauder's prestige share gains in Mainland China for the seventh consecutive quarter.

Investments and deals

In-house Toronto lab and production
The Ordinary products are conceptualised, developed and produced in DECIEM's Toronto lab and production facilities, which the CEO says gives the lab team freedom to explore new technologies and ingredients.
Standalone stores in Malaysia
The Ordinary opened its first Malaysian boutiques in Pavilion Kuala Lumpur and Mid Valley Megamall, designed as experiences with skincare education.
Sustainability strategy
DECIEM's CEO said the company is "actively building our sustainability strategy", acknowledging there is still much to be done.

Challenges and risks

Tariffs
Estée Lauder expects tariffs to hurt fiscal 2027 profitability and cash flows, which affects its brands including The Ordinary.
Hype and trust in beauty
The CEO describes an industry where consumers are asking smarter questions and says "trust will continue to become the most valuable currency in beauty", so brands must keep up on transparency.
Keeping the ethos while expanding
DECIEM enters new markets only when it can deliver the same values and customer experience, prioritising integrity over rapid growth, which can slow rollout.
Western market and duty-free headwinds at group level
Estée Lauder's outlook names challenges in key Western markets, duty-free retailer changes at the Beijing and Shanghai airports and the Middle East conflict.

What leadership says

“We don't play in the 'exclusivity' space. We only launch a formula when it's ready, effective and makes sense for our community.”

Nicola Kilner, Co-founder and CEO of DECIEM · Buro 24/7 Malaysia interview, 2025-09-11

“We currently have a 3-year plan in development for new product innovations”

Nicola Kilner, Co-founder and CEO of DECIEM · The Peak Malaysia interview, 2025-12-06

“we are gaining in Skin Care in volume and in value”

Stéphane de La Faverie, President and CEO, The Estée Lauder Companies · Estée Lauder fiscal 2027 first quarter earnings call, 2026-11-02

Where a supplier can help

Retail and education tooling for new stores
The Ordinary's Malaysian boutiques are built as experiences with tailored skincare education; suppliers of in-store consultation, training or store technology can tie to the standalone-store roll-out.
Formulation, stability and ingredient testing
With in-house development in Toronto and a 3-year innovation plan flexible around ingredient efficacy and formulation stability, ingredient, testing and lab-equipment suppliers have a fit.
Sustainability data and packaging
DECIEM says it is building its sustainability strategy, so suppliers of footprint measurement and sustainable packaging could help define actions.
Consumer-reach and campaign analytics
The Ordinary's growth came from targeted expanded consumer reach and key campaigns, which is relevant to media, social commerce and consumer-insight providers.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like DECIEM | THE ABNORMAL BEAUTY COMPANY?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about DECIEM | THE ABNORMAL BEAUTY COMPANY

What is DECIEM?

DECIEM, The Abnormal Beauty Company, is a Toronto-based beauty group and the parent of The Ordinary, and it also has NIOD, Avestan and Loopha. It is owned by The Estée Lauder Companies.

How big is The Ordinary?

Estée Lauder places The Ordinary in its Scaling Brands tier, with net sales of $400 million to under $1,000 million. Its CEO said in fiscal 2026 it posted double-digit organic sales growth.

Who leads DECIEM?

Nicola Kilner is described as co-founder and CEO of DECIEM in 2025 interviews. The Ordinary was co-founded with Brandon Truaxe.

What is The Ordinary's strategy?

It offers science-led, ingredient-focused skin care at fair prices, launches only when a formula is ready, and expands market by market, with Malaysia the latest. Estée Lauder also uses its playbook at the entry of prestige.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)